Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European multiinstitutional study. (Record no. 23817347)

MARC details
000 -LEADER
fixed length control field 02272 a2200625 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516212554.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201506s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1938-0682
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.clgc.2014.03.012
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Bamias, Aristotle
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20150608
245 00 - TITLE STATEMENT
Title Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European multiinstitutional study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical genitourinary cancer
Date of publication, distribution, etc. Oct 2014
300 ## - PHYSICAL DESCRIPTION
Extent 373-83 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Multicenter Study
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bone Neoplasms
General subdivision secondary
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Brain Neoplasms
General subdivision secondary
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Renal Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytoreduction Surgical Procedures
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Europe
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indoles
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kidney Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Metastasis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nephrectomy
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrroles
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retrospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sunitinib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vascular Endothelial Growth Factor A
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tzannis, Kimon
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Papatsoris, Athanasios
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Oudard, Stéphane
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Beuselinck, Benoit
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Escudier, Bernard
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Liontos, Michalis
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Elaidi, Thierry-Reja
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chrisofos, Michael
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stravodimos, Konstantinos
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Anastasiou, Ioannis
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mitropoulos, Dionisios
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Deliveliotis, Charalambos
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Constantinides, Constantinos
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dimopoulos, Meletios-Athanasios
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bamia, Christina
773 0# - HOST ITEM ENTRY
Title Clinical genitourinary cancer
Related parts vol. 12
-- no. 5
-- p. 373-83
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.clgc.2014.03.012">https://doi.org/10.1016/j.clgc.2014.03.012</a>
Public note Available from publisher's website

No items available.